Deferiprone has anti-inflammatory properties and reduces fibroblast migration in vitro

Scientific Reports
Mahnaz RamezanpourS Vreugde

Abstract

Normal wound healing is a highly regulated and coordinated process. However, tissue injury often results in inflammation with excessive scar tissue formation after 40-70% of operations. Here, we evaluated the effect of the iron chelator deferiprone on inflammation and the migration of primary nasal fibroblasts and primary human nasal epithelial cells (HNECs) in vitro. The cytotoxicity of deferiprone was examined by the lactate dehydrogenase assay on primary nasal fibroblasts and air-liquid interface (ALI) cultures of HNECs. Wound closure was observed in scratch assays by using time-lapse confocal scanning laser microscopy. Interleukin-6 (IL-6) and type I and III collagen protein levels were determined by ELISA. Intracellular Reactive Oxygen Species (ROS) activity was measured by utilizing the fluorescent probe H2DCFDA. Deferiprone at 10 mM concentration was non-toxic to primary fibroblasts and HNECs for up to 48 hours application. Deferiprone had significant dose-dependent inhibitory effects on the migration, secreted collagen production and ROS release by primary nasal fibroblasts. Deferiprone blocked Poly (I:C)-induced IL-6 production by HNECs but did not alter their migration in scratch assays. Deferiprone has the potential ...Continue Reading

References

Jul 1, 1992·British Journal of Plastic Surgery·Y W Tang
Aug 1, 1995·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·M P Goldman, R E Fitzpatrick
Jan 16, 1999·European Journal of Dermatology : EJD·B Berman, F Flores
Jul 9, 1999·Biotechnology and Bioengineering·K LiJ W Frost
Sep 2, 1999·The New England Journal of Medicine·A J Singer, R A Clark
Sep 22, 1999·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·R S English, P D Shenefelt
Mar 13, 2002·Journal of Tissue Viability·Ginny Puzey
Jul 5, 2003·Current Biology : CB·Paul MartinScott R McKercher
Jul 23, 2004·Thrombosis and Haemostasis·Julia V DoviLuisa A DiPietro
Sep 24, 2005·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Meinhard Wlaschek, Karin Scharffetter-Kochanek
Oct 6, 2005·Trends in Cell Biology·Paul Martin, S Joseph Leibovich
Oct 26, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jonathan P LeeAziz Ghahary
Mar 24, 2006·American Journal of Physical Medicine & Rehabilitation·Peter C EsselmanJames A Fauerbach
Sep 30, 2006·The Journal of Surgical Research·Sander ten RaaHans Jeekel
Apr 17, 2007·The Journal of Investigative Dermatology·Sabine WernerHans Smola
Feb 6, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Alexander AnzarutEdward E Tredget
May 16, 2008·Nature·Geoffrey C GurtnerMichael T Longaker
Jun 19, 2008·BMC Neurology·Sergio GoncalvesPierre Rustin
Nov 16, 2010·The Surgical Clinics of North America·Sanjay MunireddyAdrian Barbul
May 25, 2012·International Wound Journal·Mehrdad MohammadpourAfshin Fassihi
Sep 14, 2013·The Cochrane Database of Systematic Reviews·Lisa O'Brien, Daniel J Jones
Feb 24, 2016·Mediators of Inflammation·Mahnaz RamezanpourSarah Vreugde
Feb 27, 2016·International Forum of Allergy & Rhinology·Katharina RichterSarah Vreugde
Oct 13, 2017·International Forum of Allergy & Rhinology·Mahnaz RamezanpourAlkis James Psaltis
Jun 6, 2018·Frontiers in Microbiology·Mian L OoiPeter-John Wormald
Jul 29, 2018·Scientific Reports·Mahnaz RamezanpourSarah Vreugde

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Anova
R

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.